Carol McKenzie, MD
Gynecology · Coral Springs, FLNPI 1497869366
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations.
Across 108 payments — averaging $27.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$635
- AbbVie$538
- Amgen$425
- Astellas Pharma US Inc$338
- Therapeuticsmd, Inc.$217
- Agile Therapeutics, Inc.$92
- plus $756 from 18 others
What the payments were for
- Food & beverage$2,98299%
- Education$181%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 21 | $635 |
| AbbVie(2 entities) | 22 | $538 |
| Amgen | 8 | $425 |
| Astellas Pharma US Inc | 12 | $338 |
| Therapeuticsmd, Inc. | 7 | $217 |
| Agile Therapeutics, Inc. | 5 | $92 |
| Intuitive Surgical | 1 | $90 |
| Myovant Sciences Inc. | 1 | $86 |
| Pfizer | 4 | $75 |
| Hologic Sales And Service, LLC | 3 | $65 |
| Sumitomo Pharma America, Inc. | 3 | $64 |
| Millicent US Inc | 3 | $61 |
| Coopersurgical, Inc. | 4 | $54 |
| Boston Scientific | 1 | $53 |
| Exeltis, USA Inc. | 2 | $42 |
| Lupin Inc. | 3 | $39 |
| Lilly USA, LLC | 1 | $29 |
| Duchesnay USA Incorporated | 1 | $22 |
| AMAG Pharmaceuticals, Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Virtus Pharmaceuticals LLC | 1 | $13 |
| Avion Pharmaceuticals | 1 | $13 |
| Roche Diagnostics Corporation | 1 | $12 |
| Channel Medsystems, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXTSTELLIS$247
- EVENITY$125
- Prolia$125
- ANNOVERA$123
How this compares
$3,000 in reported general payments places this provider in the 80th percentile of 290 gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 118 | $10,316 |
| YuvafemEstradiol | 18 | $2,155 |
| ValacyclovirValacyclovir Hcl | 11 | $522 |
| Raloxifene Hcl | 13 | $481 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Coral Springs
- Aileen CaceresKissimmee$406K
- Parveen VahoraNew Port Richey$327K
- James KondrupVenice$310K
- Andrea GallowayThe Villages$252K
- Jessica VaughtOrlando$129K
- Steven ChavoustieMiami$113K
- Marshall BovelskyMelbourne$52K
- Minda NeimarkFt Lauderdale$46K
- Meenakshi JainSt Petersburg$35K
- Michael SpragueWeston$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.